Patents/Assignees

Beijing Giluntide Pharmaceutical Co., Ltd.

2 patents in portfolio

US12576170utility2026
Rk Polypeptide Radiopharmaceutical Targeting HER2 and Preparation Method Thereof
0 cites
US12357712utility2025
Targeted Radiopharmaceutical for Tumor and Its Use in the Imaging-guided Combination Therapy of Targeted Radiotherapy and Immunotherapy
0 cites